Welcome to Bull Street Buzz — Wednesday, August 13th 2025, 6:12am — Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease - Novartis — Swiss sneaker company On beats sales estimates, raises guidance despite Vietnam tariffs - CNBC — The great "rebalancing" in EV lithium has begun - Axios